Tarsus Pharmaceuticals TARS is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement.
Analysts estimate that Tarsus Pharmaceuticals will report an earnings per share (EPS) of $-0.94.
The market awaits Tarsus Pharmaceuticals's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
Last quarter the company beat EPS by $0.05, which was followed by a 13.72% increase in the share price the next day.
Here's a look at Tarsus Pharmaceuticals's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.93 | -1.20 | -1.36 | -1.36 |
| EPS Actual | -0.88 | -1.01 | -1.31 | -1.28 |
| Price Change % | 14.000000000000002% | -9.0% | -3.0% | 12.0% |
Performance of Tarsus Pharmaceuticals Shares
Shares of Tarsus Pharmaceuticals were trading at $49.08 as of November 11. Over the last 52-week period, shares are up 173.73%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Tarsus Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
